Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety

被引:0
|
作者
Lembo, Anthony
Dove, Scott
Andrae, David
Davenport, J. Michael
McIntyre, Gail
Almenoff, June
Covington, Paul S.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
929d
引用
收藏
页码:S159 / S159
页数:1
相关论文
共 50 条
  • [41] Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Oh, Joo Hyun
    Jang, Yeon Sil
    Kang, Danbee
    Chang, Dong Kyung
    Min, Yang Won
    NUTRIENTS, 2019, 11 (12)
  • [42] A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome
    Matsueda, Kei
    Harasawa, Shigeru
    Hongo, Michio
    Hiwatashi, Nobuo
    Sasaki, Daisuke
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (10) : 1202 - 1211
  • [43] The Effect of Phloroglucinol in Diarrhea-Dominant Irritable Bowel Syndrome: Randomized, Double-Blind, Placebo-Controlled Trial
    Cha, Bong Ki
    Choi, Chang Hwan
    Kim, Beom Jin
    Oh, Hyoung-Chul
    Kim, Jeong Wook
    Do, Jae Hyuk
    Kim, Jae G.
    Chang, Se Kyung
    GASTROENTEROLOGY, 2011, 140 (05) : S611 - S612
  • [44] The effect of phloroglucinol in diarrhea-dominant irritable bowel syndrome: randomized, double-blind, placebo-controlled trial
    Cha, B. K.
    Choi, C. H.
    Yang, S. Y.
    Song, I. D.
    Kim, S. W.
    Huh, C.
    Kim, B. J.
    Do, J. H.
    Kim, J. G.
    Chang, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 10 - 10
  • [45] Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
    Chey, William D.
    Lembo, Anthony J.
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (05): : 763 - 774
  • [46] Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial
    Das, Aakash Deep
    Ghosh, Shubhamoy
    Palanisamy, Chithra
    Guha, Nilanjana
    Mandal, Sanjukta
    Maiti, Shukdeb
    Nath, Arunava
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2023, 19 (04) : 519 - 527
  • [47] Two randomized, double-blind, placebo-controlled phase 3 trials of linaclotide in adults with irritable bowel syndrome: effects on quality of life
    Carson, R.
    Tourkodimitris, S.
    Lewis, B. E.
    Johnston, J. M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 29 - 29
  • [48] VSL#3 use in a Double-Blinded, Placebo-Controlled Pilot Trial in Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Abernathy, Frank W.
    Kenche, Harshavadran
    Stolfi, Adrienne
    GASTROENTEROLOGY, 2010, 138 (05) : S230 - S230
  • [49] Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Tomita, Toshihiko
    Fukui, Hirokazu
    Morishita, Daisuke
    Mori, Sumire
    Oshima, Tadayuki
    Shinzaki, Shinichiro
    Miwa, Hiroto
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [50] The efficacy and safety of compound glutamine entersoluble capsule in the treatment of diarrhea predominant irritable bowel syndrome: A multicenter randomized, double blinded, placebo-controlled withdrawal trial
    Bai, Tao
    Liu, Xinghuang
    Jiang, Xueliang
    Guo, Yuting
    Zheng, Min
    Tang, Wenfu
    Fang, Xiangming
    Liu, Chengxia
    Wang, Shasha
    Wu, Yongdong
    Tang, Jianrong
    Chen, Yunwang
    Yu, Huisheng
    Wu, Jieqiong
    Song, Ying
    Zhao, Qinghua
    Zhang, Qing
    Wei, Yisheng
    Tong, Qiaoyun
    Deng, Huiqiu
    Gu, Yongsong
    Liu, Deliang
    Li, Yan
    Ma, Maoyuan
    Hou, Xiaohua
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36